Helix Acquisition(HLXB) - Prospectus

Table of Contents As filed with the Securities and Exchange Commission on August 29, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. (Exact Name of Registrant as Specified in Its Certificate of Incorporation) (State or Other Jurisdiction of Incorporation or Organization) Delaware 001-41955 39-3690783 ( Commission File Number) (I.R.S. Employer Identificatio ...